(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.92%) $83.08
(-1.16%) $1.619
(-0.30%) $2 340.10
(0.00%) $27.54
(0.54%) $927.10
(-0.16%) $0.933
(-0.18%) $11.00
(-0.23%) $0.799
(0.00%) $92.17
-0.05% $ 0.200
Live Chart Being Loaded With Signals
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally...
Stats | |
---|---|
Volumen de hoy | 881 574 |
Volumen promedio | 134 777 |
Capitalización de mercado | 18.24M |
EPS | $0.0100 ( 2023-08-15 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.86 |
ATR14 | $0.161 (16.48%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-04-27 | Robinson James George | Buy | 40 000 | Common Stock |
2023-04-25 | Robinson James George | Buy | 40 000 | Common Stock |
2023-04-25 | Robinson James George | Buy | 40 000 | Common Stock |
2022-05-02 | Robinson James George | Buy | 1 151 515 | Warrant |
2021-04-22 | Robinson James George | Buy | 200 | Common Stock |
INSIDER POWER |
---|
100.00 |
Last 100 transactions |
Buy: 1 546 252 | Sell: 0 |
Volumen Correlación
Nymox Pharmaceutical Corp Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Nymox Pharmaceutical Corp Correlación - Moneda/Commodity
Nymox Pharmaceutical Corp Finanzas
Annual | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $0 (0.00 %) |
EPS: | $-0.0735 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $0 (0.00 %) |
EPS: | $-0.0735 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-0.150 |
FY | 2020 |
Ingresos: | $5 000.00 |
Beneficio Bruto: | $1 000.00 (20.00 %) |
EPS: | $-0.160 |
Financial Reports:
No articles found.
Nymox Pharmaceutical Corp
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperplasia, and Phase II clinical trials for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. In addition, it offers AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimer's disease, as well as researches and develops drug treatments for Alzheimer's disease. The company was founded in 1989 and is headquartered in Nassau, the Bahamas.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico